A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

December 18, 2019

Study Completion Date

December 18, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

AG881 Formulation 1

AG881 uncoated tablets

DRUG

AG881 Formulation 2

AG881 film-coated tablets

DRUG

Omeprazole

Omeprazole capsules

Trial Locations (1)

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY